Given that SIRPα can suppress tumor cell survival and more important, SIRPα is induced by ATO treatment in APL cells, the rapid induction of SIRPα in APL cells may serve as a novel prognostic marker for ATO treatment. The gene discussed is SIRPA; the disease is acute promyelocytic leukemia.